Medical Marijuana Inc. Stands By EU CBD Approval As Media Reports Call Into Question Firm's Claims
Executive Summary
Medical Marijuana Inc. says claims that it has lost its licence to sell CBD as a food supplement in Bulgaria are incorrect. The firm tells HBW Insight it has in fact been granted additional approval to export CBD products from Bulgaria to Russia.
You may also be interested in...
Sweden's Hemp-Derived CBD Market Under Threat Following Supreme Court Ruling
CBD from industrial hemp that contains any trace of THC, however small, is a controlled drug, Sweden's Supreme Court has ruled. The country has moved to close a legal loophole that was being taken advantage of by retailers to avoid prosecution for selling CBD oils as supplements.
Medical Marijuana Inc. Claims First CBD Supplement Approval In EU
Bulgaria has granted US-based Medical Marijuana Inc. the right to sell CBD as a supplement in a first for an EU country. The move, which will see CBD regulated as a traditional food, puts Bulgaria directly at odds with the European Commission, which recently classified the cannabis plant extract as a novel food.
With CBD Poised To Become A Novel Food In Europe, Industry Must Think Ahead To Gain Advantage
Europe's dynamic CBD market could soon see tighter regulation, after the European Commission (EC) last month added the ingredient to its Novel Food Catalogue. Regulatory expert Janet Worrell argues that the time is now for CBD industry players to act to get ahead of this potentially transformative development.